Hoping For A New Dawn In UK’s Value-Based Procurement
Executive Summary
The UK’s MedTech Directorate is undergoing a partial relaunch, with a new director set to take the reins and a new strategy being finalized. The medtech industry hopes the renewed impetus will put long-overdue attention to value-based procurement for medtech goods.
You may also be interested in...
UK Medtech Strategy Before 2022 Year End, Government Promises
The UK government’s new procurement-and-beyond body housed in the DHSC says a medtech strategy could hit the presses before 2023. The medtech industry is cheered by promises of engagement.
UK Regulatory System Progress And New MedTech Directorate Unveiled At Industry Meeting
In the three months since Brexit, UK medtech stakeholders have seen the beginnings of new regulations, foreign trade plans being put in place, and perhaps new perceptions of medtech’s value.
All About Value – Brexit Aside, UK Industry Sees Good Things Ahead For Healthtech Adoption
ABHI director of value and access Luella Trickett talks about the importance of real-world evidence in product development and value-based procurement in secondary care in the UK.